Protecting the Kidney During HF Therapy: The ROSE-AHF Study

Protecting the Kidney During HF Therapy: The ROSE-AHF Study

Late Breaking Clinical Trial: ROSE-AHF with Dr. Horng ChenПодробнее

Late Breaking Clinical Trial: ROSE-AHF with Dr. Horng Chen

Ultrafiltration for HF with Cardiorenal Syndrome: CARRESSing the Kidneys?Подробнее

Ultrafiltration for HF with Cardiorenal Syndrome: CARRESSing the Kidneys?

Mayo Genomic Discovery: Protecting Kidney Function During Heart FailureПодробнее

Mayo Genomic Discovery: Protecting Kidney Function During Heart Failure

Understanding and Protecting the Kidney: Identifying Patients at High Risk for Kidney FailureПодробнее

Understanding and Protecting the Kidney: Identifying Patients at High Risk for Kidney Failure

ACC 21: The CONNECT-HF TrialПодробнее

ACC 21: The CONNECT-HF Trial

A strategy to protect your heart.Подробнее

A strategy to protect your heart.

AHA 2010 | ASCEND-HFПодробнее

AHA 2010 | ASCEND-HF

Biomarkers for Kidney Injury: Will They Ever Be Used in Clinical Practice?Подробнее

Biomarkers for Kidney Injury: Will They Ever Be Used in Clinical Practice?

The Upside of a Heart Attack: It Could Protect Your Kidneys … TemporarilyПодробнее

The Upside of a Heart Attack: It Could Protect Your Kidneys … Temporarily

ACC 2021: The SAFE-PAD StudyПодробнее

ACC 2021: The SAFE-PAD Study

New Insights into the Diagnosis and Treatment of AKI in Patients with ADHFПодробнее

New Insights into the Diagnosis and Treatment of AKI in Patients with ADHF

Doctors warn of hidden risks for heart disease | ABC7Подробнее

Doctors warn of hidden risks for heart disease | ABC7

Heart Your Kidneys: Join the MovementПодробнее

Heart Your Kidneys: Join the Movement

ESC TV at ACC.17 - LEVO-CTS: Levosimendan - Patients With Left Ventricular Systolic DysfunctionПодробнее

ESC TV at ACC.17 - LEVO-CTS: Levosimendan - Patients With Left Ventricular Systolic Dysfunction

Professor Neil Poulter - BP and Diabetes – protecting the target organs.Подробнее

Professor Neil Poulter - BP and Diabetes – protecting the target organs.

LEVO CTS Primary Outcomes for Cardiac Surgery with LevosimendanПодробнее

LEVO CTS Primary Outcomes for Cardiac Surgery with Levosimendan

RELAXing, Regrouping, and Rethinking PDE-5 Inhibition with Sildenafil in HF-PEFПодробнее

RELAXing, Regrouping, and Rethinking PDE-5 Inhibition with Sildenafil in HF-PEF

ACC 22: 3-year Efficacy Outcomes from the SPYRAL HTN-ON MED Med Pilot Study | Prof Felix MahfoudПодробнее

ACC 22: 3-year Efficacy Outcomes from the SPYRAL HTN-ON MED Med Pilot Study | Prof Felix Mahfoud

Why Nephrologists Need to Think Twice About Phosphorus ManagementПодробнее

Why Nephrologists Need to Think Twice About Phosphorus Management

Популярное